衰老与临床前阿尔茨海默病中细微认知 decline 的客观标准:系统综述
研究发现SCD定义通常分为6类,其中基于多个神经心理测验切点的客观SCD(Obj-SCD)和Pre-MCI标准最常用。需要进一步头对头比较这些方法以确定最具预后价值的分类。
要点
- 客观SCD分类主要有6种方法,Obj-SCD和Pre-MCI最常用。
- Obj-SCD使用多个神经心理测验的切点(如-1 SD)定义。
- Pre-MCI标准基于临床痴呆评定量表0.5但神经心理测验正常。
核心结论
- 现有文献中识别出6种有前景的客观SCD分类方法,其中Obj-SCD和Pre-MCI方法最常用。
- 需要进一步头对头比较SCD方法以确定最具预后价值的分类,尤其是在种族/民族多样化的老年人中。
研究设计与样本
- 纳入标准:同行评议研究、描述离散的客观SCD分类、参与者年龄50岁以上且无轻度认知障碍(MCI)或痴呆、聚焦衰老或阿尔茨海默病(AD)。
- 共纳入70项病例对照研究,使用改良Newcastle-Ottawa量表评估质量,由2名作者提取数据并分类描述。
主要发现
- 初步识别1361篇出版物,最终70项病例对照研究符合纳入标准。
- SCD定义分为6类:基于单一认知测验特定切点(n=6)、基于认知复合分数切点(如第10百分位)(n=9)、基于多个个体神经心理测验切点(如-1 SD)的客观SCD(Obj-SCD)(n=24)、基于临床痴呆评定量表0.5但神经心理测验正常的Pre-MCI标准(n=12)、基于纵向认知 decline 速率(如超过1年)的切点(n=13)、数据驱动/聚类分类方法(n=8)。
- 两项研究使用了多种分类方法。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Although the Alzheimer's Association (AA) biomarker-only Alzheimer disease (AD) criteria and the International Working Group clinical-pathologic AD criteria differ, both approaches appreciate the need for early detection efforts. Within the AA approach, clinical stage 2 recognizes that someone can be cognitively unimpaired but still experience "subtle cognitive decline" (SCD) measured by subjective report or objective decline using neuropsychological measures. While significant attention has been given to subjective cognitive decline methods, there are no systematic examinations of the operational definition of SCD using objective neuropsychological measures. Therefore, the primary aim of this review was to identify and describe the approaches used to classify objective SCD. METHODS: A systematic literature search was performed using PubMed/MEDLINE, Web of Science, and PsycInfo databases for articles with dates ranging from the start of the database through November 1, 2023. Included studies were peer-reviewed, described a discrete objective SCD category, included participants aged 50+ without mild cognitive impairment (MCI) or dementia, and focused on aging or AD. A modified Newcastle-Ottawa Scale was used to assess the quality of included studies. Data were extracted by the 2 authors who then categorized and described the classification approaches. RESULTS: Of the 1,361 publications initially identified, 70 case-control studies met criteria for inclusion. SCD definitions generally fell into 6 categories based on using similar methodology: (1) SCD based on a specified cutoff on a single cognitive test (n = 6); (2) SCD based on a cutoff (e.g., 10th percentile) on a cognitive composite score (n = 9); (3) objectively defined SCD (Obj-SCD) using cutoffs (e.g., -1 SD) on multiple individual neuropsychological measures (n = 24); (4) "Pre-MCI" criteria defined using a Clinical Dementia Rating of 0.5 but normal performance on neuropsychological testing (n = 12); (5) cutoff based on longitudinal rate of cognitive decline (e.g., over 1 year) (n = 13); and (6) data-driven/clustering approach to classification (n = 8). Two studies used multiple classification approaches. DISCUSSION: Six promising classification approaches were identified in the existing literature, with the Obj-SCD and Pre-MCI approaches being the most commonly applied. Additional work is needed to compare SCD approaches head-to-head to identify the most prognostically useful, particularly within racially/ethnically diverse older adults.
引用
- Thomas KR, Edmonds EC. Objective Criteria for Subtle Cognitive Decline in Aging and Preclinical Alzheimer Disease: A Systematic Review. Neurology. 2025. PMID: 40198863. doi:10.1212/WNL.0000000000213536
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。